Brookfield, Cameco plan IPO of jointly owned nuclear power company Westinghouse August 1, 2026 theglobeandmail.com
FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease August 1, 2026 manilatimes.net